These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27278115)

  • 1. Expression of VEGFR and PDGFR-α/-β in 187 canine nasal carcinomas.
    Gramer I; Killick D; Scase T; Chandry D; Marrington M; Blackwood L
    Vet Comp Oncol; 2017 Sep; 15(3):1041-1050. PubMed ID: 27278115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor tyrosine kinase expression and phosphorylation in canine nasal carcinoma.
    Hocker SE; Higginbotham ML; Schermerhorn T; Henningson J
    Res Vet Sci; 2017 Dec; 115():484-489. PubMed ID: 28783596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PDGFR-α, PDGFR-β, VEGFR-2 and CD117 expression in canine mammary tumours and evaluation of the in vitro effects of toceranib phosphate in neoplastic mammary cell lines.
    Gattino F; Maniscalco L; Iussich S; Biasato I; Martano M; Morello E; Gola C; Millán Ruiz Y; Saeki N; Buracco P; Martín de Las Mulas J; De Maria R
    Vet Rec; 2018 Aug; 183(7):221. PubMed ID: 29440590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of platelet-derived growth factor and its receptors in spontaneous canine hemangiosarcoma and cutaneous hemangioma.
    Asa SA; Murai A; Murakami M; Hoshino Y; Mori T; Maruo K; Khater A; El-Sawak A; el-Aziz EA; Yanai T; Sakai H
    Histol Histopathol; 2012 May; 27(5):601-7. PubMed ID: 22419024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiproliferative effects of masitinib and imatinib against canine oral fibrosarcoma in vitro.
    Milovancev M; Helfand SC; Marley K; Goodall CP; Löhr CV; Bracha S
    BMC Vet Res; 2016 Jun; 12():85. PubMed ID: 27259510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemistry Screening of Different Tyrosine Kinase Receptors in Canine Solid Tumors-Part I: Proposal of a Receptor Panel to Predict Therapies.
    Dos Anjos DS; Civa PAS; Werner J; Vicente IST; Fonseca-Alves CE
    Int J Mol Sci; 2024 Aug; 25(15):. PubMed ID: 39126006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrasting prognostic implications of platelet-derived growth factor receptor-β and vascular endothelial growth factor receptor-2 in patients with angiosarcoma.
    Yonemori K; Tsuta K; Ando M; Hirakawa A; Hatanaka Y; Matsuno Y; Chuman H; Yamazaki N; Fujiwara Y; Hasegawa T
    Ann Surg Oncol; 2011 Oct; 18(10):2841-50. PubMed ID: 21409488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical analysis of expression of VEGFR2, KIT, PDGFR-β, and CDK4 in canine urothelial carcinoma.
    Setyo LC; Donahoe SL; Shearer PL; Wang P; Krockenberger MB
    J Vet Diagn Invest; 2023 Mar; 35(2):109-115. PubMed ID: 36648148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the platelet-derived growth factor receptor in prostate cancer and treatment implications with tyrosine kinase inhibitors.
    Hofer MD; Fecko A; Shen R; Setlur SR; Pienta KG; Tomlins SA; Chinnaiyan AM; Rubin MA
    Neoplasia; 2004; 6(5):503-12. PubMed ID: 15548358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of receptor tyrosine kinase targets PDGFR-β, VEGFR2 and KIT in canine transitional cell carcinoma.
    Walters L; Martin O; Price J; Sula MM
    Vet Comp Oncol; 2018 Mar; 16(1):E117-E122. PubMed ID: 28884928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of platelet-derived growth factor receptor-α/ß, vascular endothelial growth factor receptor-2, c-Abl, and c-Kit in canine granulomatous meningoencephalitis and necrotizing encephalitis.
    Song JH; Yu DH; Hwang TS; Seung BJ; Sur JH; Kim YJ; Jung DI
    Vet Med Sci; 2020 Nov; 6(4):965-974. PubMed ID: 32585777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Biomarkers Between Hepatic Tumors in Rat Models and a Dog.
    Kim S; Kim Y; Kim SE; Kim HJ
    In Vivo; 2023; 37(1):252-261. PubMed ID: 36593028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of genomic mutation and immunohistochemistry of platelet-derived growth factor receptors in canine vascular tumours.
    Abou Asa S; Mori T; Maruo K; Khater A; El-Sawak A; Abd el-Aziz E; Yanai T; Sakai H
    Vet Comp Oncol; 2015 Sep; 13(3):237-45. PubMed ID: 23611531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of ponatinib in vitro effect in three canine mast cell tumor cell lines expressing FGFR-1, PDGFR-α, and VEGFR-2.
    Fisher CJ; Lejeune AT; Dark MJ; Hernandez OM; Shiomitsu K
    Vet J; 2021 Mar; 269():105621. PubMed ID: 33593493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationships of platelet-derived growth factor, microvascular proliferation, and tumor cell proliferation in canine high-grade oligodendrogliomas: Immunohistochemistry of 45 tumors and an AFOB-01 xenograft mouse model.
    Yoshida K; Chambers JK; Uchida K
    Vet Pathol; 2024 Sep; 61(5):732-742. PubMed ID: 38577818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-derived growth factors and receptors in Canine Lymphoma.
    Aricò A; Guadagnin E; Ferraresso S; Gelain ME; Iussich S; Rütgen BC; Mazzariol S; Marconato L; Aresu L
    J Comp Pathol; 2014 Nov; 151(4):322-8. PubMed ID: 25172054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glomerular expression of platelet-derived growth factor (PDGF)-A, -B chain and PDGF receptor-alpha, -beta in human diabetic nephropathy.
    Uehara G; Suzuki D; Toyoda M; Umezono T; Sakai H
    Clin Exp Nephrol; 2004 Mar; 8(1):36-42. PubMed ID: 15067514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of platelet-derived growth factor receptor alpha in breast cancer is associated with tumour progression.
    Carvalho I; Milanezi F; Martins A; Reis RM; Schmitt F
    Breast Cancer Res; 2005; 7(5):R788-95. PubMed ID: 16168125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PDGFRs expression in dogs affected by malignant oral melanomas: correlation with prognosis.
    Iussich S; Maniscalco L; Di Sciuva A; Iotti B; Morello E; Martano M; Gattino F; Buracco P; De Maria R
    Vet Comp Oncol; 2017 Jun; 15(2):462-469. PubMed ID: 26833575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the therapeutic potential of masitinib and expression of its specific targets c-Kit, PDGFR-α, PDGFR-β, and Lyn in canine prostate cancer cell lines.
    Klose K; Packeiser EM; Granados-Soler JL; Hewicker-Trautwein M; Murua Escobar H; Nolte I
    Vet Comp Oncol; 2022 Sep; 20(3):641-652. PubMed ID: 35384248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.